NVCR insider buying and SEC filings, explained
NovoCure Ltd · CIK 1645113
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.3M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 4, 2026 | Sale | Frank X Leonard (CEO) sold 34,273 shares at about $17.93 ($615K). Holdings down 7% to 459,520 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 5, 2026 |
| Jun 2, 2026 | Sale | Kristin Stafford (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 21% to 11,324 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | Allyson J Ocean (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 21% to 11,324 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | Timothy J Scannell (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 17% to 14,288 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | W. Anthony Vernon (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 1% to 197,657 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | David Hung (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 13% to 20,465 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | Gabriel Leung (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 3% to 89,499 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | Jeryl L. Hilleman (Director) sold 2,945 shares at about $15.77 ($46K). Holdings down 18% to 13,861 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Mar 4, 2026 | Sale | Nicolas Leupin (Former Chief Medical Officer) sold 1,100 shares at about $13.31 ($15K). Holdings down 1% to 102,979 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Christoph Brackmann (CFO) sold 6,412 shares at about $13.31 ($85K). Holdings down 3% to 182,842 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4–5, 2026 | Sale | Mukund Paravasthu (President / COO) sold 48,623 shares between Mar 4 and Mar 5 at about $13.72 ($667K). Holdings down 40% to 72,832 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Michal Nath Puri (Chief Human Resources Officer) sold 1,100 shares at about $13.31 ($15K). Holdings down 1% to 201,322 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Frank X Leonard (CEO) sold 5,607 shares at about $13.31 ($75K). Holdings down 1% to 493,793 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 4, 2026 | Sale | Uri Weinberg (Chf Medical and Innovation Ofr) sold 6,412 shares at about $13.31 ($85K). Holdings down 2% to 267,190 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Mar 3, 2026 | Sale | William F. Doyle (Chair and Director) sold 71,887 shares at about $12.98 ($933K). Holdings down 18% to 328,397 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 5, 2026 |
| Feb 27–Mar 2, 2026 | Sale | Mukund Paravasthu (President / COO) sold 1,963 shares between Feb 27 and Mar 2 at about $13.62 ($27K). Holdings down 3% to 76,343 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Sale | Nicolas Leupin (Former Chief Medical Officer) sold 1,029 shares at about $13.66 ($14K). Holdings down 1% to 104,079 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Sale | Michal Nath Puri (Chief Human Resources Officer) sold 1,441 shares at about $13.66 ($20K). Holdings down 1% to 162,322 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 27–Mar 2, 2026 | Sale | Frank X Leonard (CEO) sold 16,966 shares between Feb 27 and Mar 2 at about $13.59 ($231K). Holdings down 5% to 349,400 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 27–Mar 2, 2026 | Sale | Uri Weinberg (Chf Medical and Innovation Ofr) sold 10,733 shares between Feb 27 and Mar 2 at about $13.68 ($147K). Holdings down 5% to 223,477 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
33 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NVCR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.